Main
>
ONCOLOGY (**)
>
Leukemia>Myeloid>Acute>IDH1+ R/R
>
Treatment
>
FR. S. Ivosidenib 250 mg Tab.
>
Company
This data is not available for free
Company's products
This section has no products